156 related articles for article (PubMed ID: 37434241)
21. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
22. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
23. HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome.
Adeyemo A; Esezobor C; Solarin A; Abeyagunawardena A; Kari JA; El Desoky S; Greenbaum LA; Kamel M; Kallash M; Silva C; Young A; Hunley TE; de Jesus-Gonzalez N; Srivastava T; Gbadegesin R
Am J Kidney Dis; 2018 Mar; 71(3):399-406. PubMed ID: 29277510
[TBL] [Abstract][Full Text] [Related]
24. [POPULATION AND CLUSTER APPROACH TO ASSESSMENT OF REPRODUCTIVE HEALTH OF WOMEN].
Gulzoda M; Khalimova F; Shukurov F; Gulin A
Georgian Med News; 2017 Sep; (270):38-45. PubMed ID: 28972481
[TBL] [Abstract][Full Text] [Related]
25. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
26. Invasive ductal breast cancer molecular subtype prediction by MRI radiomic and clinical features based on machine learning.
Sheng W; Xia S; Wang Y; Yan L; Ke S; Mellisa E; Gong F; Zheng Y; Tang T
Front Oncol; 2022; 12():964605. PubMed ID: 36172153
[TBL] [Abstract][Full Text] [Related]
27. Radiomics signature on 3T dynamic contrast-enhanced magnetic resonance imaging for estrogen receptor-positive invasive breast cancers: Preliminary results for correlation with Oncotype DX recurrence scores.
Nam KJ; Park H; Ko ES; Lim Y; Cho HH; Lee JE
Medicine (Baltimore); 2019 Jun; 98(23):e15871. PubMed ID: 31169691
[TBL] [Abstract][Full Text] [Related]
28. Association of human leukocyte antigen (HLA)-DQ and HLA-DQA1/DQB1 alleles with Vogt-Koyanagi-Harada disease: A systematic review and meta-analysis.
Liu B; Deng T; Zhu L; Zhong J
Medicine (Baltimore); 2018 Feb; 97(7):e9914. PubMed ID: 29443768
[TBL] [Abstract][Full Text] [Related]
29. Computed tomography radiomics signature via machine learning predicts
Li Q; Long X; Lin Y; Liang R; Li Y; Ge L
J Gastrointest Oncol; 2023 Jun; 14(3):1462-1477. PubMed ID: 37435222
[TBL] [Abstract][Full Text] [Related]
30. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
31. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
Fan Y; Yu Y; Wang X; Hu M; Hu C
BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.
Mao N; Shi Y; Lian C; Wang Z; Zhang K; Xie H; Zhang H; Chen Q; Cheng G; Xu C; Dai Y
Eur Radiol; 2022 May; 32(5):3207-3219. PubMed ID: 35066632
[TBL] [Abstract][Full Text] [Related]
33. A radiomics model development via the associations with genomics features in predicting axillary lymph node metastasis of breast cancer: a study based on a public database and single-centre verification.
Chen H; Wang X; Lan X; Yu T; Li L; Tang S; Liu S; Jiang F; Wang L; Zhang J
Clin Radiol; 2023 Mar; 78(3):e279-e287. PubMed ID: 36623978
[TBL] [Abstract][Full Text] [Related]
34. 3D DCE-MRI Radiomic Analysis for Malignant Lesion Prediction in Breast Cancer Patients.
Militello C; Rundo L; Dimarco M; Orlando A; Woitek R; D'Angelo I; Russo G; Bartolotta TV
Acad Radiol; 2022 Jun; 29(6):830-840. PubMed ID: 34600805
[TBL] [Abstract][Full Text] [Related]
35. Mammography-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in breast cancer.
Tan H; Wu Y; Bao F; Zhou J; Wan J; Tian J; Lin Y; Wang M
Br J Radiol; 2020 Jul; 93(1111):20191019. PubMed ID: 32401540
[TBL] [Abstract][Full Text] [Related]
36. MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols.
Wang T; Wang H; Wang Y; Liu X; Ling L; Zhang G; Yang G; Zhang H
J Ovarian Res; 2022 Jan; 15(1):6. PubMed ID: 35022079
[TBL] [Abstract][Full Text] [Related]
37. Molecular Subtypes Recognition of Breast Cancer in Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging Phenotypes from Radiomics Data.
Li W; Yu K; Feng C; Zhao D
Comput Math Methods Med; 2019; 2019():6978650. PubMed ID: 31827586
[TBL] [Abstract][Full Text] [Related]
38. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
[TBL] [Abstract][Full Text] [Related]
39. Radiomics Features on Magnetic Resonance Images Can Predict C5aR1 Expression Levels and Prognosis in High-Grade Glioma.
Wu Z; Yang Y; Zha Y
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760630
[TBL] [Abstract][Full Text] [Related]
40. MRI-Based Radiomics Nomogram: Prediction of Axillary Non-Sentinel Lymph Node Metastasis in Patients With Sentinel Lymph Node-Positive Breast Cancer.
Qiu Y; Zhang X; Wu Z; Wu S; Yang Z; Wang D; Le H; Mao J; Dai G; Tian X; Zhou R; Huang J; Hu L; Shen J
Front Oncol; 2022; 12():811347. PubMed ID: 35296027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
